[Novel anticancer compounds induce apoptosis in human tumor cells].
Gartel
Andrei L
AL
Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA. agartel@uic.edu
D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D003606:Dacarbazine / Q000494:pharmacology; D000072278:Forkhead Box Protein M1; D051858:Forkhead Transcription Factors / Q000037:antagonists & inhibitors; D006801:Humans; D064549:Myeloid Cell Leukemia Sequence 1 Protein; D009705:Nucleosides / Q000494:pharmacology*; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000037:antagonists & inhibitors; D011743:Pyrimidines / Q000494:pharmacology*
C509961:4-amino-6-hydrazino-7-beta-D-ribofuranosyl-7H-pyrrolo(2,3-d)-pyrimidine-5-carboxamide; D000970:Antineoplastic Agents; C107585:FOXM1 protein, human; D000072278:Forkhead Box Protein M1; D051858:Forkhead Transcription Factors; D064549:Myeloid Cell Leukemia Sequence 1 Protein; D009705:Nucleosides; D019253:Proto-Oncogene Proteins c-bcl-2; D011743:Pyrimidines; D003606:Dacarbazine; D051057:Proto-Oncogene Proteins c-akt